Trial: 201807049

A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 757 in Subjects with Small Cell Lung Cancer

Phase

I (Cancer Control)

Principal Investigator

Govindan, Ramaswamy

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov